Voyager Therapeutics Inc
SWB:VT6
Voyager Therapeutics Inc
SWB:VT6
Price:
2.69
EUR
0.3%
Market Cap:
€35.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Voyager Therapeutics Inc
SWB:VT6
|
US |
|
XR Immersive Tech Inc
OTC:FNTTF
|
CA |
|
S
|
Superior Industries International Inc
XBER:SPD
|
US |
|
E
|
Enanta Pharmaceuticals Inc
F:9EP
|
US |
|
C
|
Clover Leaf Capital Corp
XTSX:CLVR.P
|
CA |
|
Nihon Parkerizing Co Ltd
TSE:4095
|
JP |
|
Television Francaise 1 SA
OTC:TVFCF
|
FR |
|
M
|
Middle Island Resources Ltd
SWB:M83
|
AU |
|
N
|
Norrland Gold Corp
F:8VC
|
CA |
|
G
|
Galane Gold Ltd
OTC:GGGOF
|
CA |
Wall St Price Targets
VT6 Price Targets Summary
Voyager Therapeutics Inc
Voyager Therapeutics Inc
Wall Street analysts forecast VT6 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for VT6 is 12.09 EUR with a low forecast of 6.43 EUR and a high forecast of 20.89 EUR.
Lowest Forecast
Price Target
6.43
EUR
139% Upside
Average Forecast
Price Target
12.09
EUR
349% Upside
Highest Forecast
Price Target
20.89
EUR
677% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VT6's stock price target?
Price Target
12.09
EUR
12.09
EUR
According to Wall Street analysts, the average 1-year price target for VT6 is 12.09 EUR with a low forecast of 6.43 EUR and a high forecast of 20.89 EUR.
What is the Revenue forecast for Voyager Therapeutics Inc?
Projected CAGR
42%
42%
The compound annual growth rate for Revenue over the next 8 years is 42%.
